Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Rare Cannabinoid Company Launches New Informational Website On THCV, CBDV, CBN, CBG, CBC, CBDA, CBD, Delta-8-THC And Terpenes

RareCannabinoidCompany has launched a new website designed to help hemp and cannabis consumers learn how specific rarecannabinoidsandterpenesmay improve their mental and physical health. The website -rarecannabinoidco.com- offers a wealth of information and links to scientific research onTHCV,CBDV,CBN,CBG,CBC,CBDA,CBD, Delta-8-THC andterpenes. People can explore the website in a variety of ways, including a new "Shop By Need" function which shows the bestcannabinoidsfor "Sleep," "Energy and Focus," "Stress Relief," "Discomfort," "MoodEnhancers," "Appetite Suppression" and "Nausea." For those seeking even more specialized care, they can find acannabinoidhealth advisor near them.


News provided by

Rare Cannabinoid Company

Nov 09, 2021, 04:45 ET

Share this article

Share toX

Share this article

Share toX

Rare Cannabinoid Company's new website is education focused with links to scientific studies on THCV, CBDV, CBN, CBG, CBC, Delta-8-THC, CBDA, CBN, and terpenes.
Rare Cannabinoid Company's new website is education focused with links to scientific studies on THCV, CBDV, CBN, CBG, CBC, Delta-8-THC, CBDA, CBN, and terpenes.

HONOLULU, Hawaii, Nov. 8, 2021 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company has launched a new website designed to help hemp and cannabis consumers learn how specific rare cannabinoids and terpenes may improve their mental and physical health. The website - rarecannabinoidco.com - offers a wealth of information and links to scientific research on THCV, CBDV, CBN, CBG, CBC, CBDA, CBD, Delta-8-THC and terpenes. People can explore the website in a variety of ways, including a new "Shop By Need" function which shows the best cannabinoids for "Sleep," "Energy and Focus," "Stress Relief," "Discomfort," "Mood Enhancers," "Appetite Suppression" and "Nausea." For those seeking even more specialized care, they can find a cannabinoid health advisor near them.

"People want to know what each cannabinoid does and how it can help them," said Rare Cannabinoid Company founder and CEO Jared Dalgamouni.

People want to know what each cannabinoid does and how it can help them

Post this

"We designed this site to make it easy and enjoyable to learn about these natural compounds and their unique properties," he said.

"Education is so important and yet so often lacking in the cannabis and hemp space," Dalgamouni said.

Rare or minor cannabinoids are compounds found in hemp, cannabis, and other plants that are believed to offer specific wellness benefits. However, unlike CBD and THC, they naturally occur in extremely small amounts. Thanks to recent advances in breeding, extraction, and technology, they can now be produced in large enough quantities to be sold on their own. Meanwhile, terpenes are oils that also produce certain effects. They are increasingly believed to be responsible for the differences in aroma and feel of different cannabis strains.

Each rare cannabinoid and terpene offers very different effects. For example: THCV acts like a stimulant, increasing energy and suppressing appetite, while CBN is best for relaxation and sleep. Others have more niche uses, such as CBDA, which may ease nausea, and CBDV, which is being studied for potential benefits for people with autism spectrum disorder and muscular dystrophy.

By isolating each of these cannabinoids and terpenes, Rare Cannabinoid Company encourages people to mix and match them as needed for their personalized care.

"We hope people will do their research, use our links to studies in the National Library of Medicine and British Journal of Pharmacology, and find out what works for them," said Dalgamouni.

"People can use our information and products to take control of their cannabinoid regime, creating different blends for morning, night, or depending how they're feeling," he said.

Rare Cannabinoid Company currently offers an apothecary line of high strength single extracts of rare cannabinoids - THCV, CBDV, CBN, CBG, CBC, CBDA, CBD, and Delta-8-THC, and terpene-only blends for relaxation and discomfort relief. Those products are intended to be combined with their full spectrum Rare Hawaiian CBD, or one's own favorite full or broad spectrum oil, for the entourage effect.

For those who want a simpler, one-and-done oil, they offer 1:1 blends of THCV, CBG, CBN, or CBC pre-blended with full spectrum Rare Hawaiian CBD.

They are also about to launch high potency cannabinoid gummies, each containing a large amount of THCV, CBN, CBG or CBD. They are intended to be a tasty way to experience the brand's mix-and-match apothecary concept.

Another unique feature of the website is a map and list of cannabinoid health advisors. For people with specific ailments who need more specialized care, this can be a very useful feature. The list is comprised of doctors, nurses, clinicians, and naturopathic doctors who are knowledgeable about CBD, THC, rare cannabinoids, terpenes and the brand's specific products. They are independent advisors who offer appointments in office or by phone or video. The company is actively seeking to develop relationships with more cannabis/hemp advisors. Interested, qualified advisors can email [email protected].

The site also has a map of the more than 200 locations stocking its products across the United States. It also shows independent lab reports, explains how products are produced in a cGMP certified facility, and keeps its blog up-to-date with articles on the latest research into cannabinoids and products.

Rare Cannabinoid Company is an American company based in Hawaii. It was established in Q1 2020 and is a pioneer in the "rare" or "minor" cannabinoid industry, offering purified tinctures and gummies of rare cannabinoid and terpenes as well as blends with full spectrum Hawaiian CBD.

It is the sister brand of Hawaiian Choice, which was established in Q4 2017. Hawaiian Choice is a luxury, lifestyle brand that combines premium broad spectrum Hawaiian CBD with organic and wild crafted Hawaiian fruits, essential oils and honey in an assortment of tinctures, gummies, salves and pet products.

Stores interested in stocking Rare Cannabinoid Company and/or Hawaiian Choice products can request a wholesale account at Wellness Orders.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, +1 (808)762-1313, [email protected]

Twitter, LinkedIn

SOURCE Rare Cannabinoid Company

Modal title

Rare Cannabinoid Company offers CBN (cannabinol) in tinctures and gummies for rest and sleep.
Rare Cannabinoid Company offers CBN (cannabinol) in tinctures and gummies for rest and sleep.
THCV acts like a stimulant, increasing energy and decreasing hunger. Rare Cannabinoid Company sells THCV gummies and tinctures.
THCV acts like a stimulant, increasing energy and decreasing hunger. Rare Cannabinoid Company sells THCV gummies and tinctures.
Rare Cannabinoid Company offers CBN (cannabinol) in tinctures and gummies for rest and sleep. THCV acts like a stimulant, increasing energy and decreasing hunger. Rare Cannabinoid Company sells THCV gummies and tinctures.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.